Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Cutting Q4 and Out-Year Incivek Estimates
Go back to Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Cutting Q4 and Out-Year Incivek Estimates| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 540.26 -11.8 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $552.06 | 52 Week High | $134.71 | |||
| Open | $543.78 | 52 Week Low | $73.31 | |||
| Day High | $548.99 | P/E | N/A | |||
| Day Low | $538.27 | EPS | $-1.98 | |||
| Volume | 1,055,304 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
